SETBP1 and Alzheimer disease: We focused most of our in vitro work on PBMCs from healthy subjects, replicating similar findings in blood from small numbers of AD patients, but we were not powered to adequately study differences between healthy and AD groups in vitro, including responsiveness to SEB, TSLP, or NOD2L.